Xact Bio: Funding, Investors & Team (Oct 2026)
Xact Bio is a biotechnology company that develops extra-hepatic siRNA delivery for RNA medicines.
Xact Bio has raised $10.0M across 1 funding round on record, the most recent an undisclosed round of $10.0M announced in Sep 2026.
That round is above the $7.6M median round size for United States companies tracked on FundedIQ over the last two years.
Xact Bio Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Xact Bio Funding Rounds
Xact Bio Funding in Context
Xact Bio's latest round of $10.0M is above the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Xact Bio in Biopharma and Boston
Companies Similar to Xact Bio
Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for…
Onyx is a research collective building a virtual immune system from longitudinal human immune data.
Hone creates AI agents that can help run a business, joining a crowded field of services using the technology…
Sonilo provides an AI video-to-music platform that generates synchronized, commercially usable soundtracks…
PlotPicks is an interactive entertainment platform that combines television viewing with prediction-based…
Negosh operates a data-driven platform and marketplace that connects brand owners with manufacturers and…
Insuraviews provides software for analyzing insurance rate filings with search, analytics, and competitive…
Thrixel is an AI-powered 3D model generation platform designed to integrate directly with coding agents, AI…
Vye Health is an AI-native healthcare company that provides tools for medical providers to launch and run…
Park Golf Pitch & Putt is a sports company that focuses on outdoor entertainment with focus on pitch-putt…
Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed Platform & AI With…
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Xact Bio Funding FAQs
What does Xact Bio do?
Xact Bio is a biotechnology company that develops extra-hepatic siRNA delivery for RNA medicines.
How much funding has Xact Bio raised?
Xact Bio has raised $10.0M across 1 round on record. The most recent is an undisclosed round of $10.0M announced in Sep 2026.
When did Xact Bio last raise funding?
Xact Bio's most recent funding round on record is an undisclosed round of $10.0M, announced in Sep 2026.
Where is Xact Bio headquartered?
Xact Bio is based in Boston, United States.
When was Xact Bio founded?
Xact Bio was founded in 2024.
About FundedIQ's Xact Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Xact Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.